HALO Shares Outstanding History



Below is a table of the HALO shares outstanding history going back to 3/1/2010:

Date HALO Shares Outstanding
3/1/201091.71M
5/3/201091.89M
8/2/201092.02M
11/2/2010100.43M
3/1/2011101.39M
5/2/2011102.81M
8/1/2011103.62M
11/2/2011103.69M
3/1/2012112.09M
4/30/2012112.44M
8/2/2012112.69M
10/31/2012112.71M
2/25/2013113.12M
5/6/2013113.16M
5/16/2013113.12M
8/5/2013113.29M
11/4/2013114.03M
2/24/2014124.00M
5/5/2014124.51M
8/5/2014125.31M
11/5/2014125.39M
2/24/2015126.70M
5/6/2015127.26M
8/6/201512.77M
11/2/2015128.01M
2/22/2016129.06M
5/2/2016129.14M
8/2/2016129.41M
11/1/2016129.49M
2/22/2017129.76M
5/1/2017129.84M
8/1/2017141.92M
11/1/2017142.36M
2/13/2018143.08M
5/3/2018143.97M
7/31/2018144.30M
10/30/2018144.56M
2/14/2019145.03M
4/30/2019145.51M
7/31/2019146.31M
11/7/2019146.54M
2/14/2020138.23M
8/5/2020137.03M
10/28/2020135.18M
2/17/2021135.28M
5/5/2021142.39M
8/3/2021142.33M
10/25/2021140.79M
2/14/2022137.70M
5/4/2022137.95M
8/2/2022137.78M
10/31/2022135.21M
2/14/2023135.37M
4/28/2023131.68M
7/31/2023131.92M
10/31/2023132.10M
2/12/2024126.82M

Also see: HALO Market Cap History
HALO YTD Return
HALO Historical Shares Outstanding:
+2.35% CAGR
HALO Historical Shares Outstanding: +2.35% CAGR

Mouse over chart for data details
3/1/2010 ...2/12/2024
Halozyme Therapeutics is a biopharma technology platform company that provides solutions to improve patient experience and outcomes. Co.'s approved product and its collaborators' approved products and product candidates are based on rHuPH20, its patented recombinant human hyaluronidase enzyme. Co. refers to the application of rHuPH20 to facilitate the delivery of other drugs or fluids as its ENHANZE® drug delivery technology (ENHANZE). Co. licenses the ENHANZE technology to form collaborations with biopharmaceutical companies that develop or market drugs requiring or benefiting from injection via the subcutaneous route of administration. We show 57 historical shares outstanding datapoints in our coverage of HALO's shares outstanding history.

Understanding the changing numbers of HALO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like HALO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching HALO by allowing them to research HALO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree HALO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Halozyme Therapeutics (HALO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

HARP Shares Outstanding History
HBIO Shares Outstanding History
HCA Shares Outstanding History
HCWB Shares Outstanding History
HEPA Shares Outstanding History
HGEN Shares Outstanding History
HILS Shares Outstanding History
HJLI Shares Outstanding History
HLTH Shares Outstanding History
HLVX Shares Outstanding History
More Healthcare companies »

 

HALO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.